Prospector Partners LLC Johnson & Johnson Transaction History

Prospector Partners LLC

$915 Million
Q3 2024

A detailed history of Prospector Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Prospector Partners LLC holds 66,647 shares of JNJ stock, worth $10.3 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

66,647

Previous 66,134 0.78%

Holding current value

$10.3 Million

Previous $9.67 Million 11.73%

% of portfolio

1.18%

Previous 1.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$145.48 - $167.38 $74,631 - $85,865	513 Added 0.78%	66,647 $10.8 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $95,290 - $104,134	660 Added 1.01%	66,134 $9.67 Million
Q1 2024 May 09, 2024	BUY	$155.22 - $162.74 $769,115 - $806,376	4,955 Added 8.19%	65,474 $10.4 Million
Q4 2023 Feb 09, 2024	BUY	$145.6 - $158.88 $3.67 Million - $4.01 Million	25,225 Added 71.47%	60,519 $9.49 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $909,580 - $1.02 Million	-5,840 Reduced 14.2%	35,294 $5.5 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $54,022 - $58,138	350 Added 0.86%	41,134 $6.81 Million
Q1 2023 May 08, 2023	BUY	$151.05 - $180.26 $45,315 - $54,078	300 Added 0.74%	40,784 $6.32 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $2.44 Million - $2.74 Million	-15,250 Reduced 27.36%	40,484 $7.15 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $3.78 Million - $4.21 Million	-23,426 Reduced 29.59%	55,734 $9.11 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $622,303 - $688,237	3,700 Added 4.9%	79,160 $14.1 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $6.93 Million - $7.88 Million	43,850 Added 138.72%	75,460 $13.4 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $62,372 - $69,204	-400 Reduced 1.25%	31,610 $5.41 Million
Q3 2021 Nov 10, 2021	SELL	$161.5 - $179.47 $524,875 - $583,277	-3,250 Reduced 9.22%	32,010 $5.17 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $1.19 Million - $1.27 Million	-7,450 Reduced 17.44%	35,260 $5.81 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $841,885 - $937,640	-5,500 Reduced 11.41%	42,710 $7.02 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $726,683 - $834,114	-5,300 Reduced 9.9%	48,210 $7.59 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $70,190 - $76,915	-500 Reduced 0.93%	53,510 $7.97 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $313,008 - $377,889	-2,430 Reduced 4.31%	54,010 $7.6 Million
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $972,475 - $1.35 Million	8,750 Added 18.35%	56,440 $7.4 Million
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $1.1 Million - $1.26 Million	8,600 Added 22.0%	47,690 $6.96 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $264,056 - $295,651	-2,080 Reduced 5.05%	39,090 $5.06 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $2.2 Million - $2.42 Million	-16,771 Reduced 28.94%	41,170 $5.73 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $447,563 - $497,652	-3,560 Reduced 5.79%	57,941 $8.1 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $222,340 - $267,590	-1,810 Reduced 2.86%	61,501 $7.94 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $121,580 - $142,880	1,000 Added 1.6%	63,311 $8.75 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $51,342 - $56,656	-430 Reduced 0.69%	62,311 $7.56 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $163,881 - $194,063	-1,310 Reduced 2.05%	62,741 $8.04 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $257,847 - $282,213	-1,965 Reduced 2.98%	64,051 $8.95 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $75,092 - $78,520	-580 Reduced 0.87%	66,016 $8.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	66,596	66,596 $8.81 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospector Partners LLC with notifications on news.

Account

Prospector Partners LLC Johnson & Johnson Transaction History